eXagen DIAGNOSTICS, Inc. Product Pipeline Analysis

SUMMARY

eXagen DIAGNOSTICS, Inc. Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a eXagen DIAGNOSTICS, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List Of Tables 5
1.2 List of Figures 6
2 Company Overview 7
2.1 Key Information 7
2.2 Financial Performance 7
2.3 Industry Outlook -- In Vitro Diagnostics 7
3 Major Products and Services 8
3.1 Overview 8
4 Competitors 9
5 Key Employees 10
6 Locations And Subsidiaries 11
6.1 Head Office 11
7 Recent Developments 12
7.1 Corporate Communications 12
7.1.1 Nov 01, 2007: Exagen Diagnostics Appoints New Board Member 12
7.1.2 Apr 27, 2007: Exagen Diagnostics Appoints Marketing Director 12
8 eXagen DIAGNOSTICS, Inc. Pipeline Products 13
8.1 eXagen DIAGNOSTICS, Inc. Product Pipeline Analysis 13
8.1.1 eXagen DIAGNOSTICS, Inc. Pipeline Products By Equipment Type 13
8.1.2 eXagen DIAGNOSTICS, Inc. Pipeline Products By Development Stage 15
8.1.3 eXagen DIAGNOSTICS, Inc. Pipeline Products By Therapy Area 16
8.2 Chromosomal aberration test 16
8.2.1 Product Description 16
8.2.2 Product Status 16
8.3 Hepatitis C Tests 17
8.3.1 Product Description 17
8.3.2 Product Status 17
8.4 eXagenBC(ER/PR+) 17
8.4.1 Product Description 17
8.4.2 Product Status 18
8.4.3 Pricing 18
8.5 eXagenBC(ER/PR-) 18
8.5.1 Product Description 18
8.5.2 Product Status 18
8.5.3 Pricing 19
8.6 qPCR assay 19
8.6.1 Product Description 19
8.6.2 Product Status 19
8.7 qPCR assay(inflammatory bowel disease) 20
8.7.1 Product Description 20
8.7.2 Product Status 20
9 Appendix 21
9.1 Methodology 21
9.1.1 Coverage 21
9.1.2 Secondary Research 22
9.1.3 Primary Research 22
9.1.4 Expert Panel Validation 23
9.2 Contact Us 23
9.3 About Global Markets Direct 23
9.4 Disclaimer 23

1.1 List Of Tables
Table 1: eXagen DIAGNOSTICS, Inc.,Key Facts 7
Table 2: eXagen DIAGNOSTICS, Inc., Key Employees, 10
Table 3: eXagen DIAGNOSTICS, Inc. Pipeline Products by Equipment Type 14
Table 4: eXagen DIAGNOSTICS, Inc. Pipeline Products By Development Stage 15
Table 5: eXagen DIAGNOSTICS, Inc. Pipeline Products By Therapy Area 16

1.2 List of Figures
Figure 1: eXagen DIAGNOSTICS, Inc. Pipeline Products By Equipment Type 13
Figure 2: eXagen DIAGNOSTICS, Inc. Pipeline Products By Equipment Type 14
Figure 3: eXagen DIAGNOSTICS, Inc. Pipeline Products By Development Stage 15
Figure 4: Global Markets Direct Methodology 21